When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OYST - FDA accepts Oyster Point Pharma's varenicline nasal spray application
Oyster Point Pharma Inc.
The FDA has accepted Oyster Point Pharma's (OYST) New Drug Application ((NDA)) for OC-01 (varenicline) nasal spray for the treatment of signs and symptoms of dry eye disease.The PDUFA target action date is October 17.At present, FDA has stated that it does not intend to hold an advisory committee meeting to discuss this application. The NDA submission was supported by safety and efficacy results from the Phase 3 ONSET-2, Phase 2b ONSET-1, and Phase 2 MYSTIC clinical trials.